neuropeptide-y and Cardiotoxicity

neuropeptide-y has been researched along with Cardiotoxicity* in 1 studies

Other Studies

1 other study(ies) available for neuropeptide-y and Cardiotoxicity

Article	Year
The Effects of Neuropeptide Y Overexpression on the Mouse Model of Doxorubicin-Induced Cardiotoxicity. Cardiovascular toxicology, 2020, Volume: 20, Issue:3 Doxorubicin is a potent anticancer drug with cardiotoxicity hampering its use. Neuropeptide Y (NPY) is the most abundant neuropeptide in the heart and a co-transmitter of the sympathetic nervous system that plays a role in cardiac diseases. The aim of this work was to study the impact of NPY on doxorubicin-induced cardiotoxicity. Transgenic mice overexpressing NPY in noradrenergic neurons (NPY-OE Topics: Adrenergic Neurons; Animals; Body Composition; Calcium Signaling; Cardiotoxicity; Disease Models, Animal; Doxorubicin; Heart Diseases; Male; Mice, Inbred C57BL; Mice, Transgenic; Myocytes, Cardiac; Neuropeptide Y; Stroke Volume; Up-Regulation; Ventricular Function, Left; Ventricular Remodeling; Weight Gain	2020

Article

Year

The Effects of Neuropeptide Y Overexpression on the Mouse Model of Doxorubicin-Induced Cardiotoxicity.

Cardiovascular toxicology, 2020, Volume: 20, Issue:3

Doxorubicin is a potent anticancer drug with cardiotoxicity hampering its use. Neuropeptide Y (NPY) is the most abundant neuropeptide in the heart and a co-transmitter of the sympathetic nervous system that plays a role in cardiac diseases. The aim of this work was to study the impact of NPY on doxorubicin-induced cardiotoxicity. Transgenic mice overexpressing NPY in noradrenergic neurons (NPY-OE

Topics: Adrenergic Neurons; Animals; Body Composition; Calcium Signaling; Cardiotoxicity; Disease Models, Animal; Doxorubicin; Heart Diseases; Male; Mice, Inbred C57BL; Mice, Transgenic; Myocytes, Cardiac; Neuropeptide Y; Stroke Volume; Up-Regulation; Ventricular Function, Left; Ventricular Remodeling; Weight Gain

2020